Cumberland Pharmaceuticals (CPIX) Income from Non-Controlling Interests (2016 - 2025)
Cumberland Pharmaceuticals (CPIX) has disclosed Income from Non-Controlling Interests for 16 consecutive years, with -$16950.0 as the latest value for Q4 2025.
- Quarterly Income from Non-Controlling Interests fell 878.59% to -$16950.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$28583.0 through Dec 2025, down 179.28% year-over-year, with the annual reading at -$28583.0 for FY2025, 179.28% down from the prior year.
- Income from Non-Controlling Interests hit -$16950.0 in Q4 2025 for Cumberland Pharmaceuticals, down from -$8282.0 in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $43791.0 in Q1 2024 to a low of -$36561.0 in Q4 2021.
- Historically, Income from Non-Controlling Interests has averaged -$10949.2 across 5 years, with a median of -$14254.0 in 2022.
- Biggest five-year swings in Income from Non-Controlling Interests: soared 320.08% in 2024 and later plummeted 878.59% in 2025.
- Year by year, Income from Non-Controlling Interests stood at -$36561.0 in 2021, then soared by 48.07% to -$18985.0 in 2022, then soared by 60.07% to -$7581.0 in 2023, then soared by 128.72% to $2177.0 in 2024, then tumbled by 878.59% to -$16950.0 in 2025.
- Business Quant data shows Income from Non-Controlling Interests for CPIX at -$16950.0 in Q4 2025, -$8282.0 in Q3 2025, and $5533.0 in Q2 2025.